Clesrovimab approval for RSV: a lifesaving opportunity for global infant health equity
{{output}}
The respiratory syncytial virus (RSV) remains the primary cause of acute lower respiratory tract infections and mortality among infants worldwide, with disproportionate deaths in low- and middle-income countries due to limited access to supportive care. The U.... ...